Work

Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders

Year: 2020

Type: article

Abstract: Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine) and valproate can be considered to be safe in combination with antiviral drugs.

Source: The British Journal of Psychiatry

DOI: 10.1192/bjp.2020.84

Authors: Kai Zhang, Xiaoqin Zhou, Huanzhong Liu, Kenji Hashimoto

Institutions: Anhui Medical University, Chaohu Hospital of Anhui Medical University, Chiba University, Center for Forensic Mental Health, Chiba University

Language: English

Topic: COVID-19 and Mental Health

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,775